Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer release identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check24 days agoChange DetectedA site-wide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” It does not change the study information.SummaryDifference0.6%

- Check31 days agoChange DetectedThe website footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check59 days agoChange DetectedAn entry for revision v3.7.0 has been added to the study history. The previous revision v3.6.6 is no longer listed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.6.6 was added to the record history, replacing the previous revision entry 'v3.6.5'. This reflects a minor update to the page's revision metadata rather than a change to the study data.SummaryDifference0.1%

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.